Elevated expression of TMPRSS2 in the context of SARS-CoV-2 infections (15) implies that SARS-CoV-2 infection could increase chances of TMPRSS2 fusions, a phenomenon well-associated with prostate cancer development and progression (13). This evidence concerns the gene TMPRSS2 and prostate cancer.